Molecular pathology of invasive carcinoma

Annals of the New York Academy of Sciences

Volumn 880, Issue , 1999, Pages 74-82

  Longnecker, Daniel S ^a,b  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P16; PROTEIN P53;

CANCER GENETICS; CONFERENCE PAPER; CYSTADENOMA; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; INVASIVE CARCINOMA; ONCOGENE; ONCOGENE K RAS; PANCREAS ADENOCARCINOMA; PANCREAS CARCINOMA; PANCREAS DUCT; PATHOLOGY; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

EID: 0032794171     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb09511.x     Document Type: Conference Paper

References (55)

1. 1. CALDAS, C. & S.E. KERN. 1995. K-ras mutation and pancreatic adenocarcinoma: state-of-the-art. Int. J. Pancreatol. 18: 1-6.
2. 2. HAHN, S.A. & S.E. KERN. 1995. Molecular genetics of exocrine pancreatic neoplasms. Surg. Clin. North Am. 75: 857-869.
3. 3. MURAKAMI, Y. 1997. Genetic alterations in human pancreatic cancer. J. Hep. Bil. Pancr. Surg. 4: 283-290.
4. 4. LEMOINE, N.R. 1997. Molecular pathology of pancreatic duct neoplasms. In Biliary and Pancreatic Ductal Epithelia. Pathobiology and Pathophysiology. A.E. Sirica & D.S. Longnecker, Eds.: 505-525. Marcel Dekker. New York.
5. 5. HOWE, J.R. & K.C. CONLON. 1997. The molecular genetics of pancreatic cancer. Surg. Oncol. 6: 1-18.
6. 6. SLEBOS, R.J.C., H.M. CEHA, S.E. KERN et al. 1998. Molecular genetics of pancreatic cancer. In Pancreatic Cancer: Advances in Molecular Pathology, Diagnosis & Clinical Management. F.H. Sarkar & M.C. Dugan, Eds.: 65-82. BioTechniques Books. Natick, MA.
7. 7. HRUBAN, R.H., G.M. PETERSEN & S.E. KERN. 1998. Genetics of pancretic cancer. From genes to families. Surg. Oncol. Clin. North Am. 7: 1-23.
8. 8. KORC, M. 1998. Role of growth factors in pancreatic cancer. Surg. Oncol. Clin. North Am. 7: 25-41.
9. 9. BANERJEE, S.K., W.F. MAKDISI, A.P. WESTON et al. 1997. A two-step enriched-nested PCR technique enhances sensitivity for detection of codon 12 K-ras mutations in pancreatic adenocarcinoma. Pancreas 15: 16-24.
10. 10. BERROZPE, G., J. SCHAEFFER, M.A. PEINADO et al. 1994. Comparative analysis of mutations in p53 and K-ras genes in pancreatic cancer. Int. J. Cancer 58: 185-191.
11. 11. BRAT, D.J., K.D. LILLEMOE, C. YEO et al. 1998. Progression of pancreatic intraductal neoplasias to infiltrating adenocarcinoma of the pancreas. Am. J. Surg. Pathol. 22: 163-169.
12. 12. TADA, M., M. OMATA, & M. OHTO. 1991. Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma. Gastroenterology 100: 233-238.
13. 13. URBAN, T., S. RICCI, J.-D. GRANGE et al. 1993. Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas. J. Natl. Cancer Inst. 85: 2008-2012.
14. 14. MALATS, N., M. PORTA, J.M. COROMINAS et al. 1997. Ki-ras mutations in exocrine pancreatic cancer: association with clinico-pathological characteristics and with tobacco and alcohol consumption. PANK-ras I Project Investigators. Int. J. Cancer 70: 661-667.
15. 15. SUGIO, K., K. MOLBERG, J. ALBORES-SAAVEDRA et al. 1997. K-ras mutations and allelic loss at 5q and 18q in the development of human pancreatic cancers. Int. J. Pancreatol. 21: 205-217.
16. 16. RALL, C.J., Y.X. YAN, F. GRAEME-COOK et al. 1996. Ki-ras and p53 mutations in pancreatic ductal adenocarcinoma. Pancreas 12: 10-17.
17. 17. TABATA, T., T. FUJIMORI, S. MAEDA et al. 1993. The role of ras mutation in pancreatic cancer, precancerous lesions, and chronic pancreatitis. Int. J. Pancreatol. 14: 237-244.
18. 18. TSUTSUMI, M., T. TSUJIUCHI, O. ISHIKAWA et al. 1997. Increased telomerase activities in human pancreatic duct adenocarcinomas. Jpn. J. Cancer Res. 88: 971-976.
19. 19. WILENTZ, R.E., C.H. CHUNG, P.D.J. STURM et al. 1998. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma. Cancer 82: 96-103.
20. 20. LONGNECKER, D.S. & P.G. TERHUNE. 1998. What is the true rate of KRAS mutation in carcinoma of the pancreas? Pancreas 17: 323-324.
21. 21. Bos, J.L. 1989. ras Oncogenes in human cancer: a review. Cancer Res. 49: 4682-4689.
22. 22. KORNMANN, M., H.G. BEGER & M. KORC. 1998. Role of fibroblast growth factors and their receptors in pancreatic cancer and chronic pancreatitis. Pancreas 17: 169-175.
23. 23. WAKITA, K., H . OHYANAGI, K. YAMAMOTO, T. TOKUHISA & Y. SAITOH. 1992. Over-expression of c-Ki-ras and c-fos in human pancreatic carcinomas. Int. J. Pancreatol. 11: 43-47.
24. 24. LI, D.C. & T.H. LIU. 1992. Oncogene expression and point mutation in human pancreatic adenocarcinomas. Chung-hua Ping LiHsueh Tsa Chih (China) 21: 152-155.
25. 25. KIEHNE, K., K.H. HERZIG & U.R. FOLSCH. 1997. c-met expression in pancreatic cancer and effects of hepatocyte growth factor on pancreatic cancer cell growth. Pancreas 15: 35-40.
26. 26. LYNCH, H.T. & T. SMYRK. 1996. Hereditary nonpolyposis colorectal cancer (Lynch syndrome). An updated review. Cancer 78: 1149-1167.
27. 27. GOGGINS, M., C.A. GRIFFIN, K. TURNACIOGLU et al. 1998. Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild/type K-ras and characteristic histopathology: poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+. Am. J. Pathol. 152: 1501-1507.
28. 28. LYNCH, H.T., T. SMYRK, S.E. KERN et al. 1996. Familial pancreatic cancer: a review. Semin. Oncol. 23: 251-275.
29. 29. HIYAMA, E., T. KODAMA, K. SHINBARA et al. 1997. Telomerase activity is detected in pancreatic cancer but not in benign tumors. Cancer Res. 57: 326-331.
30. 30. ROZENBLUM, E., M. SCHUTTE, M. GOOGINS et al. 1997. Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res. 57: 1731-1734.
31. 31. TERHUNE, P.G., C. HEFFESS & D.S. LONGNECKER. 1994. Human pancreatic acinar cell carcinomas contain only wild-type c-K-ras codons 12, 13 and 61. Mol. Carcinog. 10: 110-114.
32. 32. PELLEGATA, N.S., F. SESSA, B. RENAULT et al. 1994. K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. Cancer Res. 54: 1556-1560.
33. 33. HOORENS, A., N.R. LEMOINE & E. MCLELLAN. 1993. Pancreatic acinar cell carcinoma: an analysis of cell lineage markers, p53 expression, and Ki-ras mutation. Am. J. Pathol. 143: 685-698.
34. 34. TERHUNE, P.G., V.A. MEMOLI & D.S. LONGNECKER. 1998. Evaluation of p53 mutation in pancreatic acinar cell carcinomas of humans and transgenic mice. Pancreas 16: 6-12.
35. 35. DUNN, J.L. & D.S. LONGNECKER. 1995. Pancreatoblastoma in an older adult. Arch. Pathol. Lab. Med. 119: 547-551.
36. 36. LEE, W.-Y., C.-C. TZENG, R.M.-Y. CHEN et al. 1997. Papillary cystic tumors of the pancreas: assessment of malignant potential by analysis of progesterone receptor, flow cytometry, and ras oncogene mutation. Anticancer Res. 17: 2587-2592.
37. 37. ISHIKAWA, T., A. NAKAO, S. NOMOTO et al. 1998. Immunohistochemical and molecular biological studies of serous cystadenoma of the pancreas. Pancreas 16: 40-44.
38. 38. TERHUNE, P.G. & D.S. LONGNECKER. 1995. Do oncogene and tumor suppressor gene abnormalities vary with type of carcinoma of the pancreas? J. Hep. Bil. Pancr. Surg. 2: 1-7.
39. 39. VORTMEYER, A., I. LUBENSKI, F. FOGT et al. 1997. Allelic deletion and mutation of the von Hippel-Lindau (VHL) tumor suppressor gene in pancreatic microcystic adenomas. Am. J. Pathol. 151: 951-956.
40. 40. SONG, M., Y. NIO, Y. SATO et al. 1996. Clinicopathological significance of Ki-ras point mutation and p21 expression in benign and malignant exocrine tumors of the human pancreas. Int. J. Pancreatol. 20: 85-93.
41. 41. KONISHI, Y., M. TSUTSUMI & D.S. LONGNECKER. 1998. Mechanistic analysis and chemoprevention of pancreatic carcinogenesis. Pancreas 17: 334-340.
42. 42. URA, H., T. OBARA, R. SHUDO et al. 1998. Selective cytotoxicity of farnesylamine to pancreatic carcinoma cells and ki-ras-transformed fibroblasts. Mol. Carcinog. 21: 93-99.
43. 43. TRUMPER, L.H., B. BURGER, F. VON BONIN et al. 1994. Diagnosis of pancreatic adenocarcinomoa by polymerase chain reaction from pancreatic secretions. Br. J. Cancer 70: 278-284.
44. 44. UEHARA, H., A. NAZAIZUMI, M. BABA et al. 1996. Diagnosis of pancreatic cancer by K-ras point mutation and cytology of pancreatic juice. Am. J. Gastroenterol. 91: 1616-1621.
45. 45. TADA, M., T. TERATANI, Y. KOMATSU et al. 1998. Quantitative analysis of ras gene mutation in pancreatic juice for diagnosis of pancreatic adenocarcinoma. Dis. Dis. Sci. 43: 15-20.
46. 46. ABBRUZZESE, J.L., D.B. EVANS, I. RAIJMAN et al. 1997. Detection of mutated c-Ki-ras in the bile of patients with pancreatic cancer. Anticancer Res. 17: 795-801.
47. 47. VAN LAETHEM, J.L., P. VERTONGEN, J. DEVIERE, et al. 1995. Detection of c-Ki-ras gene condon 12 mutations from pancreatic duct brushings in the diagnosis of pancreatic tumours. Gut 36: 781-787.
48. 48. CALDAS, C., S.A. HAHN, R.H. HRUBAN et al. 1994. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res. 54: 3568-3573.
49. 49. SORENSON, G.D., D.M. PRIBISH, F.H. VALONE et al. 1994. Soluble normal and mutated DNA sequences from single-copy genes in human blood. Cancer Epid. Biomarkers Prev. 3: 67-71.
50. 50. NOMOOTO, S., A. NAKAO, Y. KASAI et al. 1996. Detection of ras gene mutations in perioperative peripheral blood with pancreatic adenocarcinoma. Jpn. J. Cancer Res. 87: 793-797.
51. 51. MULCAHY, H.E., J. LYAUTEY, C. LEDERREY et al. 1998. A prospective study of K-ras mutations in the plasma of pancreatic cancer patients. Clin. Cancer Res. 4: 271-275.
52. 52. APPLE, S.K., J.R. HECHT, J.M. NOVAK et al. 1996. Polymerase chain reaction-based K-ras mutation detection of pancreatic adenocarcinoma in routine cytology smears. Am. J. Clin. Pathol. 105: 321-326.
53. 53. PINTO, M.M. J.R. EMANUEL, V. CHATURVEDI et al. 1997. Ki-ras mutations and the carcinembryonic antigen level in fine needle aspirates of the pancreas. Acta Cytol. 41: 427-434.
54. 54. FURUYA, N. S. KAWA, T. AKATMATSU et al. 1997. Long-term follow-up of patients with chronic pancreatitis and K-ras gene mutation detected in pancreatic juice. Gastroenterology 113: 593-598.
55. 55. TERHUNE, P.G., D.M. PHIFER, T.D. TOSTESON et al. 1998. K-ras mutation in focal proliferative lesions of human pancreas. Cancer Epid. Biomarkers Prev. 7: 515-521.